MS200647-0005
08 Dec 2020
MS200647-0005
NCT03840902
A Multicenter, Double Blind, Randomized, Controlled Study of M7824 With Concurrent Chemoradiation Followed by M7824 Versus Concurrent Chemoradiation Plus Placebo Followed by Durvalumab in Participants With Unresectable Stage III Non-small Cell Lung Cancer
EMD Serono Research & Development Institute
Cancer Type | Lung & mesothelioma |
---|---|
Trial Type | Treatment |
Phase | Phase II |
Age Range | 18 years and older |
Sex | Both |
Tumour Stream | Non-small Cell Lung Cancer |
Cancer Stage | Locally Recurrent or Locally Advanced |
Anticipated Start Date | 2019-04-16 |
Anticipated End Date | 2028-01-26 |
Hospital | Calvary Central Districts Hospital |
---|---|
Clinical Trial Coordinator | Julie Rowe |
julie.rowe@calvarycare.org.au | |
Phone | 08 8239 9536 |
Principal Investigator | Dr Rohit Joshi |
Recruitment Status | Recruitment on Hold |